Zobrazeno 1 - 5
of 5
pro vyhledávání: '"L Enriquez Olivar"'
Autor:
R Aparicio Peñacona, A Oterino Manzanas, JC Garcia Casanueva, AM Lopez Gonzalez, L Enriquez Olivar, MJ Otero
Publikováno v:
Section 4: Clinical pharmacy services.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d34d31013169c6290b911183b2f0304b
https://doi.org/10.1136/ejhpharm-2022-eahp.86
https://doi.org/10.1136/ejhpharm-2022-eahp.86
Autor:
A.M. López González, L Enriquez Olivar, E Queipo García, S Izquierdo Muñoz, MT Sánchez Sánchez, ME Cárdaba García
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background The local Pharmacy and Therapeutics Committee (PTC) approved Teriflunomide (TE) and Dimethylfumarate (DMF) for the treatment of relapsing-remitting multiple sclerosis (RRMS). These drugs were used in first-line treatment in adults with RRM
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b32c5753b34ce48c5103272403b2dc01
https://doi.org/10.1136/ejhpharm-2019-eahpconf.284
https://doi.org/10.1136/ejhpharm-2019-eahpconf.284
Autor:
A.M. López González, E Queipo García, L Enriquez Olivar, MT Sánchez Sánchez, S Izquierdo Muñoz
Publikováno v:
Section 6: Education and Research.
Background Recommendations approved by the local Pharmacy and Therapeutics Committee (PTC) for the prescription of Sacubitril/Valsartan (SV) are: patients with chronic symptomatic heart failure (HF) (II–III grade following New York Association (NYH
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dc694dd74223feb478977dcdf157c16e
https://doi.org/10.1136/ejhpharm-2019-eahpconf.602
https://doi.org/10.1136/ejhpharm-2019-eahpconf.602
Autor:
L Enriquez Olivar, E Queipo García, A Muñoz Martin, A Pariente, J Varela González-Aller, F Ramis, S Izquierdo Mñoz
Publikováno v:
Eur J Hosp Pharm
Background Pulmonary hypertension (PH) is a chronic disease with a high mortality rate. Therefore, choosing the right treatment at the right time is essential. Purpose To analyse which treatments were prescribed depending on the type of disease and t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2a58ad18eb482ef32fc78f156910bb7
https://doi.org/10.1136/ejhpharm-2018-eahpconf.509
https://doi.org/10.1136/ejhpharm-2018-eahpconf.509
Publikováno v:
European Journal of Hospital Pharmacy. 23:A198.3-A199
Background Commercial presentations of oral thioguanine suitable for dosing in paediatric patients diagnosed with acute lymphoblastic leukaemia (ALL) are not available in our country. Therefore, paediatricians in our hospital requested the pharmacy d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::da849fa792802850ffa4c05da77e69cf
https://doi.org/10.1136/ejhpharm-2016-000875.449
https://doi.org/10.1136/ejhpharm-2016-000875.449